Status:

UNKNOWN

Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive Bladder

Lead Sponsor:

DongGuk University

Collaborating Sponsors:

Korea Health Industry Development Institute

Conditions:

Overactive Bladder

Menopause

Eligibility:

FEMALE

40+ years

Phase:

NA

Brief Summary

The purpose of this study is to verify the efficacy and safety of electroacupuncture treatment of postmenopausal women with overactive bladder (OAB).

Detailed Description

The investigators targeted the patients of menopausal women with OAB. After treatment in 2 groups - electroacupuncture treatment and acupuncture treatment - the investigators will compare the improvem...

Eligibility Criteria

Inclusion

  • Women over 40 years of age without the possibility of pregnancy
  • Have a history of amenorrhea for at least 1 year and have no previous history of hormone replacement therapy for the last 6 months
  • With symptoms of urinary frequency and urgency lasting more than three months
  • Who fit the diagnostic criteria for OAB, with a total score more than three points in Korean version overactive bladder symptom score (OABSS)
  • Who have average urinary frequency of more than eight times per day and urgency which is defined as urgency rating scale (URS) on bladder diary is more than two points and/or UUI on 3-day bladder diary during one week screening period
  • Who agree to this clinical study after sufficient explanation

Exclusion

  • Diag¬nosed with UTI by urine examination
  • With stress urinary incontinence without symptoms of OAB
  • With suspected of having voiding dys¬function induced by neurological damage
  • With a medical history of cystocele, uterine pro¬lapse or similar
  • With a medical history of obstructive uropathy such as urinary stones and urinary tumors
  • With a surgical history of urethra or bladder
  • With a medical history of malignant tumors of urinary tract
  • With a medical history of neurologic disease or psychi¬atric illness
  • Have an artificial cardiac pacemaker or implantable cardioverter defibrillator in the chest
  • Have experienced a hypersensitivity reaction after an acupuncture treatment, or show any other contraindications;
  • Who participated in another clinical trial within the past three months
  • Who have taken therapeutic drugs that may affect blad¬der function within one month of the start of this study
  • With inadequate literacy to complete study documents

Key Trial Info

Start Date :

March 2 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2018

Estimated Enrollment :

98 Patients enrolled

Trial Details

Trial ID

NCT03260907

Start Date

March 2 2018

End Date

December 31 2018

Last Update

August 28 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dongguk university Bundang Oriental Hospital

Seongnam-si, Gyeonggi-do, South Korea, 13601